Works matching DE "CD19 antigen"
Results: 704
Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma.
- Published in:
- Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01222-y
- By:
- Publication type:
- Article
Peripheral Blood Lymphocyte Subsets as Biomarkers for the Severity of Inflammatory Bowel Disease Subtypes: A Cross-Sectional Study.
- Published in:
- Journal of Contemporary Medical Sciences, 2024, v. 10, n. 6, p. 411, doi. 10.22317/jcms.v10i6.1635
- By:
- Publication type:
- Article
Plasma cell‐free DNA in canine lymphoma patients as a novel material for genotyping.
- Published in:
- Veterinary & Comparative Oncology, 2024, v. 22, n. 2, p. 303, doi. 10.1111/vco.12961
- By:
- Publication type:
- Article
Optimization of canine CD20 chimeric antigen receptor T cell manufacturing and in vitro cytotoxic activity against B‐cell lymphoma.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 4, p. 739, doi. 10.1111/vco.12602
- By:
- Publication type:
- Article
Prospective evaluation of flow cytometric characteristics, histopathologic diagnosis and clinical outcome in dogs with naïve B‐cell lymphoma treated with a 19‐week CHOP protocol.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 3, p. 342, doi. 10.1111/vco.12553
- By:
- Publication type:
- Article
Glycoengineering of NK Cells with Glycan Ligands of CD22 and Selectins for B‐Cell Lymphoma Therapy.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 7, p. 3647, doi. 10.1002/ange.202005934
- By:
- Publication type:
- Article
A retrospective study on the prognostic value of preoperative C-reactive protein to albumin ratio in patients with oral cavity squamous cell carcinoma.
- Published in:
- PeerJ, 2020, p. 1, doi. 10.7717/peerj.9361
- By:
- Publication type:
- Article
Upregulation of PD-1 Expression and High sPD-L1 Levels Associated with COVID-19 Severity.
- Published in:
- Journal of Immunology Research, 2022, p. 1, doi. 10.1155/2022/9764002
- By:
- Publication type:
- Article
Upregulation of PD-1 Expression and High sPD-L1 Levels Associated with COVID-19 Severity.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab.
- Published in:
- Blood Cancer Journal, 2025, v. 14, n. 1, p. 1, doi. 10.1038/s41408-025-01217-9
- By:
- Publication type:
- Article
The intrinsic defects of T cells impact the efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00958-9
- By:
- Publication type:
- Article
CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00848-0
- By:
- Publication type:
- Article
Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00837-3
- By:
- Publication type:
- Article
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy?
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00819-5
- By:
- Publication type:
- Article
Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00792-z
- By:
- Publication type:
- Article
Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00688-4
- By:
- Publication type:
- Article
Transcriptional Coactivator BOB1 (OBF1, OCA-B) Modulates the Specificity of DNA Recognition by the POU-Domain Factors OCT1 and OCT2 in a Monomeric Configuration.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 1, p. 123, doi. 10.3390/biom14010123
- By:
- Publication type:
- Article
Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 2, p. 348, doi. 10.3390/biom13020348
- By:
- Publication type:
- Article
Targeted Epigenetic Interventions in Cancer with an Emphasis on Pediatric Malignancies.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 1, p. 61, doi. 10.3390/biom13010061
- By:
- Publication type:
- Article
Anti-BCMA Immunotoxins: Design, Production, and Preclinical Evaluation.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 10, p. 1387, doi. 10.3390/biom10101387
- By:
- Publication type:
- Article
Development of Recombinant Immunotoxins for Hairy Cell Leukemia.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 8, p. 1140, doi. 10.3390/biom10081140
- By:
- Publication type:
- Article
Intracranial Hemorrhage Following Oral Low-Dose Methotrexate After Multiple Toxicities Caused by High-Dose Methotrexate in Childhood Acute Lymphoblastic Leukemia.
- Published in:
- Frontiers in Pharmacology, 2019, p. 1, doi. 10.3389/fphar.2019.01072
- By:
- Publication type:
- Article
Coagulation FXIII-A Protein Expression Defines Three Novel Sub-populations in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia Characterized by Distinct Gene Expression Signatures.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01063
- By:
- Publication type:
- Article
Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00146
- By:
- Publication type:
- Article
Detection of impaired IgG antibody formation facilitates the decision on early immunoglobulin replacement in hypogammaglobulinemic patients.
- Published in:
- Frontiers in Immunology, 2015, v. 6, p. 1, doi. 10.3389/fimmu.2015.00032
- By:
- Publication type:
- Article
γδ T cell-mediated antibody-dependent cellular cytotoxicity with CD19 antibodies assessed by an impedance-based label-free real-time cytotoxicity assay.
- Published in:
- Frontiers in Immunology, 2014, v. 5, p. 1, doi. 10.3389/fimmu.2014.00618
- By:
- Publication type:
- Article
A Trispecific Anti-HIV Chimeric Antigen Receptor Containing the CCR5 N-Terminal Region.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2020, v. 10, p. 1, doi. 10.3389/fcimb.2020.00242
- By:
- Publication type:
- Article
CD19 as a therapeutic target in a spontaneous autoimmune polyneuropathy.
- Published in:
- Clinical & Experimental Immunology, 2014, v. 175, n. 2, p. 181, doi. 10.1111/cei.12215
- By:
- Publication type:
- Article
Improved immune recovery after transplantation of TCRαβ/CD19-depleted allografts from haploidentical donors in pediatric patients.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, p. S6, doi. 10.1038/bmt.2015.87
- By:
- Publication type:
- Article
Early evaluation of immune reconstitution following allogeneic CD3/CD19-depleted grafts from alternative donors in childhood acute leukemia.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 11, p. 1419, doi. 10.1038/bmt.2012.43
- By:
- Publication type:
- Article
Células T modificadas con receptores quiméricos de antígeno: ingeniería genética y aplicaciones clínicas en cáncer pediátrico. Revisión de la literatura.
- Published in:
- Médicas UIS, 2023, v. 36, n. 3, p. 65, doi. 10.18273/revmed.v36n3-2023006
- By:
- Publication type:
- Article
Rituximab potentially improves clinical outcomes of CAR-T therapy for r/r B-ALL via sensitizing leukemia cells to CAR-T-mediated cytotoxicity and reducing CAR-T exhaustion.
- Published in:
- Cellular Oncology (2211-3428), 2024, v. 47, n. 5, p. 1649, doi. 10.1007/s13402-024-00945-7
- By:
- Publication type:
- Article
Targeting nucleolin improves sensitivity to chemotherapy in acute lymphoblastic leukemia.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 6, p. 1709, doi. 10.1007/s13402-023-00837-2
- By:
- Publication type:
- Article
Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor (CAR) for tumor immunotherapy; recent progress.
- Published in:
- Stem Cell Research & Therapy, 2022, v. 13, n. 1, p. 1, doi. 10.1186/s13287-022-02719-0
- By:
- Publication type:
- Article
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02510-7
- By:
- Publication type:
- Article
Case series of two different dose regimen Rituximab therapy for severe Pemphigus.
- Published in:
- Italian Journal of Anatomy & Embryology / Archivio Italiano di Anatomia Ed Embriologia, 2022, v. 126, n. 2, p. 93, doi. 10.36253/ijae-13919
- By:
- Publication type:
- Article
Successful Treatment of γ-Heavy-Chain Disease with Rituximab and Fludarabine.
- Published in:
- Acta Haematologica, 2012, v. 128, n. 3, p. 139, doi. 10.1159/000339097
- By:
- Publication type:
- Article
Expression of Concern: Synthesized multiple antigenic polypeptide vaccine based on B-cell epitopes of human heparanase could elicit a potent antimetastatic effect on human hepatocellular carcinoma in vivo.
- Published in:
- PLoS ONE, 2019, v. 14, n. 12, p. 1, doi. 10.1371/journal.pone.0226124
- Publication type:
- Article
Effect of organophosphorus pesticide exposure on the immune cell phenotypes among farm women and their children.
- Published in:
- Archives of Environmental & Occupational Health, 2022, v. 77, n. 9, p. 702, doi. 10.1080/19338244.2021.2002795
- By:
- Publication type:
- Article
Functional Validation of the RQR8 Suicide /Marker Gene in CD19 CAR-T Cells and CLL1CAR-T Cells.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 6, p. 1523, doi. 10.1007/s00277-023-05227-0
- By:
- Publication type:
- Article
CD19 CAR T-cell infusion during severe COVID-19 acute respiratory distress syndrome in large B-cell lymphoma.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 1, p. 231, doi. 10.1007/s00277-022-05029-w
- By:
- Publication type:
- Article
Detection of EP300-ZNF384 fusion in patients with acute lymphoblastic leukemia using RNA fusion gene panel sequencing.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Chimeric antigen receptor therapy in hematological malignancies: antigenic targets and their clinical research progress.
- Published in:
- Annals of Hematology, 2020, v. 99, n. 8, p. 1681, doi. 10.1007/s00277-020-04020-7
- By:
- Publication type:
- Article
Right ventricular dysfunction in patients with diffuse large B-cell lymphoma undergoing anthracycline-based chemotherapy: a 2D strain and 3D echocardiography study.
- Published in:
- International Journal of Cardiovascular Imaging, 2021, v. 37, n. 4, p. 1311, doi. 10.1007/s10554-020-02120-z
- By:
- Publication type:
- Article
Left ventricular mechanics in patients with hematological malignancies before initiation of chemo- and radiotherapy.
- Published in:
- International Journal of Cardiovascular Imaging, 2021, v. 37, n. 3, p. 881, doi. 10.1007/s10554-020-02061-7
- By:
- Publication type:
- Article
News in brief.
- Published in:
- Indian Pediatrics, 2017, v. 54, n. 10, p. 889, doi. 10.1007/s13312-017-1158-3
- By:
- Publication type:
- Article
TriBAFF-CAR-T cells eliminate B-cell malignancies with BAFFR-expression and CD19 antigen loss.
- Published in:
- Cancer Cell International, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12935-021-01923-x
- By:
- Publication type:
- Article
Association of relapse-linked ARID5B single nucleotide polymorphisms with drug resistance in B-cell precursor acute lymphoblastic leukemia cell lines.
- Published in:
- Cancer Cell International, 2020, v. 20, n. 1, p. N.PAG, doi. 10.1186/s12935-020-01524-0
- By:
- Publication type:
- Article
Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01886-9
- By:
- Publication type:
- Article
BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01817-8
- By:
- Publication type:
- Article